Phospho-CBL (Tyr674) Antibody

What is Phospho-CBL (Tyr674) and its significance in cellular signaling?

Phospho-CBL (Tyr674) refers to the E3 ubiquitin-protein ligase CBL that has been phosphorylated at tyrosine residue 674. CBL (Casitas B-lineage lymphoma proto-oncogene) functions as a negative regulator of many signaling pathways triggered by activation of cell surface receptors. The phosphorylation at Tyr674 specifically alters CBL's activity and interactions with other signaling molecules.

CBL acts as an E3 ubiquitin ligase, accepting ubiquitin from specific E2 ubiquitin-conjugating enzymes and transferring it to substrates, thereby promoting their degradation by the proteasome. This mechanism is critical for regulating the activity and abundance of receptor tyrosine kinases (RTKs) and other signaling proteins. When phosphorylated at specific residues like Tyr674, CBL's activity and substrate interactions can be significantly modified, altering its regulatory functions in the cell .

What molecular weight should I expect when detecting Phospho-CBL (Tyr674)?

When detecting Phospho-CBL (Tyr674) using western blot techniques, you should expect to observe a band at approximately 120 kDa. This corresponds to the full-length E3 ubiquitin-protein ligase CBL . It's important to note that this observed molecular weight may vary slightly depending on experimental conditions, post-translational modifications, and the specific cell or tissue type being analyzed.

What species reactivity is available for Phospho-CBL (Tyr674) antibodies?

Commercial Phospho-CBL (Tyr674) antibodies demonstrate reactivity across multiple species including Human, Mouse, and Rat samples . This cross-species reactivity makes these antibodies versatile tools for comparative studies across different model organisms. When using these antibodies in non-validated species, preliminary validation experiments are recommended to confirm specificity.

What applications are Phospho-CBL (Tyr674) antibodies suitable for?

Phospho-CBL (Tyr674) antibodies are validated for multiple experimental applications including:

• Western Blot (WB): Recommended dilution range of 1/500 - 1/2000

• Immunohistochemistry (IHC): Recommended dilution range of 1/100 - 1/300

• Immunofluorescence (IF): Recommended dilution range of 1/50 - 1/200

• ELISA: Recommended dilution of 1/5000

These applications allow researchers to detect and quantify phosphorylated CBL across various experimental contexts, from protein expression analysis to cellular localization studies.

How should I validate the specificity of a Phospho-CBL (Tyr674) antibody?

Validating antibody specificity is critical for generating reliable research data. For Phospho-CBL (Tyr674) antibodies, consider the following validation approaches:

• Phosphatase treatment controls: Treat one sample with lambda phosphatase to remove phosphorylation and confirm loss of signal

• Stimulation/inhibition experiments: Use known activators of CBL phosphorylation (e.g., growth factors) or inhibitors of upstream kinases to demonstrate dynamic changes in signal

• Peptide competition assay: Pre-incubate the antibody with the phosphorylated peptide used as immunogen (amino acids 640-689 of human CBL containing phosphorylated Tyr674) to block specific binding

• Knockout/knockdown controls: Compare signal between wild-type samples and those with reduced or eliminated CBL expression

A truly specific Phospho-CBL (Tyr674) antibody should detect CBL protein only when phosphorylated at Tyr674, as indicated in the product specifications .

What is the difference between polyclonal and monoclonal Phospho-CBL (Tyr674) antibodies?

Both antibody types detect endogenous levels of CBL protein only when phosphorylated at Y674, but they offer different advantages depending on your experimental requirements .

How does CBL Tyr674 phosphorylation relate to its functional domains and activity?

CBL contains multiple functional domains that coordinate its activity as an E3 ubiquitin ligase and adaptor protein. The N-terminus is composed of a phosphotyrosine binding (PTB) domain (also called TKB domain), a short linker region, and a RING-type zinc finger. The PTB domain itself contains three different subdomains: a four-helix bundle, a calcium-binding EF hand, and a divergent SH2 domain .

Tyr674 is located outside these N-terminal domains, in a region that mediates interactions with other signaling proteins. Phosphorylation at this site can modify CBL's interactions with binding partners and affect its substrate recognition. While Tyr674 phosphorylation is important, it's worth noting that phosphorylation at other sites, such as Tyr731, induces different effects—for example, Tyr731 phosphorylation promotes the activation and recruitment of phosphatidylinositol 3-kinase to the cell membrane in osteoclast function .

What experimental approaches can detect changes in CBL Tyr674 phosphorylation?

The CBL Phospho-Tyr674 Colorimetric Cell-Based ELISA Kit offers a comprehensive approach for detecting and quantifying phosphorylated CBL in intact cells. This method provides several advantages:

• Lysate-free detection: Preserves cellular context and avoids artifacts introduced during cell lysis

• High throughput: Uses 96-well plate format for analyzing multiple conditions simultaneously

• Dual normalization: Incorporates GAPDH detection as an internal control and Crystal Violet staining to normalize for cell number

• Versatility: Suitable for screening effects of various treatments, inhibitors (e.g., siRNA, chemicals), or activators on CBL phosphorylation

The assay uses an indirect ELISA format where Phospho-CBL (Tyr674) is captured by specific primary antibodies, followed by detection with HRP-conjugated secondary antibodies that catalyze a colorimetric reaction measurable at 450 nm .

What is the role of CBL Tyr674 phosphorylation in disease contexts?

CBL functions as a proto-oncogene, and alterations in its phosphorylation status can have significant implications for disease progression. Mutations or deletions that disturb CBL's ability to down-regulate receptor tyrosine kinases (RTKs) can convert it into an oncogenic protein .

In cancer research, studying CBL phosphorylation is particularly relevant as it regulates the degradation of numerous RTKs, including KIT, FLT1, FGFR1, FGFR2, PDGFRA, PDGFRB, EGFR, CSF1R, EPHA8, and KDR . Dysregulation of these pathways is implicated in various malignancies.

CBL mutations have been found in acute myeloid leukemia, and expansion of CGG repeats in the 5' UTR has been associated with Jacobsen syndrome. Additionally, mutations in the CBL gene are the cause of Noonan syndrome-like disorder .

What are common challenges when using Phospho-CBL (Tyr674) antibodies in Western blots?

When performing Western blots with Phospho-CBL (Tyr674) antibodies, researchers may encounter several challenges:

• Loss of phosphorylation during sample preparation due to phosphatase activity: Add phosphatase inhibitors to all buffers and keep samples cold throughout preparation

• Multiple bands or unexpected molecular weights: May represent alternatively spliced variants, degradation products, or non-specific binding

• Weak or no signal: Ensure the protein of interest is abundant enough and the phosphorylation site is preserved during processing

• High background: Optimize blocking conditions, antibody dilutions, and washing procedures

To maintain phosphorylation status, use lysis buffers containing phosphatase inhibitors (e.g., sodium fluoride, sodium orthovanadate) and process samples rapidly at 4°C.

How can I optimize Cell-Based ELISA for detecting Phospho-CBL (Tyr674)?

For optimal results with the CBL Phospho-Tyr674 Colorimetric Cell-Based ELISA Kit, consider these optimization strategies:

• Cell density: Ensure consistent cell seeding (>5000 cells/well for optimal detection)

• Fixation: Use freshly prepared 4% formaldehyde and maintain consistent fixation times

• Antibody incubation: Follow recommended dilutions (Primary antibody: 1:100, HRP-conjugated secondary: as provided)

• Normalization: Always incorporate GAPDH detection and Crystal Violet staining to account for variations in cell number

• Controls: Include wells without primary antibody (negative control) and wells with known modulators of CBL phosphorylation (positive control)

The kit includes a monoclonal antibody specific for human GAPDH that serves as an internal positive control for normalizing target absorbance values, which is crucial for accurate interpretation of results .

What factors might affect Phospho-CBL (Tyr674) detection in different cell types?

The detection of Phospho-CBL (Tyr674) can vary across cell types due to several factors:

• Basal phosphorylation levels: Different cell types maintain varying levels of CBL phosphorylation under unstimulated conditions

• Expression of upstream kinases: The presence and activity of kinases that phosphorylate CBL at Tyr674 may differ between cell types

• Phosphatase activity: Variations in phosphatase expression can affect the stability of phosphorylation

• Tissue specificity: CBL shows particularly high expression in epithelium and T-cells, which may affect detection sensitivity

• Subcellular localization: CBL can localize to various cellular compartments including cytoplasm, cell membrane, cell projections (cilia), and Golgi apparatus, potentially affecting accessibility to antibodies in certain applications

When transitioning between cell types, optimization of experimental conditions is recommended to account for these variations.

What materials are typically required for Phospho-CBL (Tyr674) detection experiments?

For comprehensive Phospho-CBL (Tyr674) detection studies, the following materials are essential:

For specialized applications such as Cell-Based ELISA, additional materials include microplates, fixatives, cell staining reagents, and normalization controls .

What are the storage and stability considerations for Phospho-CBL (Tyr674) antibodies?

To maintain optimal antibody performance:

• Storage temperature: Store at -20°C for long-term stability (up to 1 year)

• Formulation: Typically provided in PBS containing 50% glycerol, 0.5% BSA, and 0.02% sodium azide

• Freeze-thaw cycles: Minimize repeated freezing and thawing by aliquoting the antibody

• Working dilutions: Prepare fresh working dilutions on the day of the experiment

• Purity: Commercial antibodies usually have ≥90% purity

Proper storage and handling of these antibodies are crucial for maintaining their specificity and sensitivity in detecting phosphorylated CBL.